Research Topics
| Yoav GolanSummaryAffiliation: Tufts Medical Center Country: USA Publications
| Collaborators |
Detail Information
Publications
Fidaxomicin, a new treatment for Clostridium difficile infectionsL Epstein
Department of Medicine, Tufts Medical Center, Boston, MA, USA
Drugs Today (Barc) 48:101-8. 2012..Additionally, fidaxomicin has minimal systemic absorption with few adverse side effects. Thus, fidaxomicin is an attractive new alternative for treatment of CDI...- Empiric anti-Candida therapy for patients with sepsis in the ICU: how little is too little?Yoav Golan
Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
Crit Care 13:180. 2009..This commentary explores the rationale for early anti-Candida strategies in the ICU and highlights the contribution and limitations of the article by Zilberberg and colleagues... - Risk factors for albicans and non-albicans candidemia in the intensive care unitJennifer K Chow
Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Tufts University School of Medicine, Boston, MA, USA
Crit Care Med 36:1993-8. 2008..To determine risk factors for bloodstream infections (BSI) with Candida non-albicans (C-NA) species and Candida albicans (CA) among critically ill patients... - Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?David A Oxman
Tufts Medical Center, 800 Washington Street, Boston, MA 02111, USA
J Antimicrob Chemother 65:1460-5. 2010..Candidaemia is often treated with fluconazole in the absence of susceptibility testing. We examined factors associated with candidaemia caused by Candida isolates with reduced susceptibility to fluconazole... - Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unitJennifer K Chow
Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Tufts University School of Medicine, Boston, Massachusetts 02111, USA
Clin Infect Dis 46:1206-13. 2008..We examined factors associated with BSIs due to non-albicans Candida species, compared with C. albicans BSIs, in an ICU patient population... - Predicting high vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus bloodstream infectionsAndrew S Lubin
Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, Massachusetts 02111, USA
Clin Infect Dis 52:997-1002. 2011..Automated testing often fails to identify these isolates. We developed a simple clinical rule to predict vancomycin MIC of 2 ?g/mL in patients with MRSA bacteremia... - Antibiotic exposure and room contamination among patients colonized with vancomycin-resistant enterococciMarci Drees
Tufts Medical Center, Tufts University, Boston, Massachusetts, USA
Infect Control Hosp Epidemiol 29:709-15. 2008..To determine whether total and antianaerobic antibiotic exposure increases the risk of room contamination among vancomycin-resistant enterococci (VRE)-colonized patients... - Vaccination of solid-organ transplantation candidatesJennifer Chow
Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts Medical Center, Boston, MA 02111, USA
Clin Infect Dis 49:1550-6. 2009..Current information on vaccination for adult solid-organ transplant candidates is reviewed... - Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysisYoav Golan
Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Boston, Massachusetts 02111, USA
Ann Intern Med 143:857-69. 2005..Mortality from invasive candidiasis is high. Low culture sensitivity and treatment delay contribute to increased mortality, but nonselective early therapy may result in excess costs and drug resistance... - Lessons learned from the anaerobe survey: historical perspective and review of the most recent data (2005-2007)David R Snydman
Div of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts 02111, USA
Clin Infect Dis 50:S26-33. 2010..The survey was conceived in 1980 to track emerging antimicrobial resistance in Bacteroides species... - The impact of gown-use requirement on hand hygiene complianceYoav Golan
Division of Geographic Medicine and Infectious Diseases, Department of Medicine, Tufts New England Medical Center, Boston, MA 02111, USA
Clin Infect Dis 42:370-6. 2006..Among the arguments supporting a gown-use requirement is the potential to boost awareness of infection control, leading to improved hand hygiene compliance... - Overview of transplant mycologyYoav Golan
Tufts University School of Medicine, Division of Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Boston, MA 02111, USA
Am J Health Syst Pharm 62:S17-21. 2005..The epidemiology, clinical manifestation, diagnosis, and management of invasive mycoses in transplant patients are described... - Emergence of fluoroquinolone resistance among Bacteroides speciesYoav Golan
Geographic Medicine and Infectious Diseases, Tufts New England Medical Center, Boston, MA, USA
J Antimicrob Chemother 52:208-13. 2003..Several newer generation fluoroquinolones have demonstrated good in vitro activity against Bacteroides species; particularly when first introduced. However, resistance of Bacteroides to quinolones appears to be increasing...